ROS-responsive nano-medicine for navigating autophagy to enhance targeted therapy of inflammatory bowel disease
Authors:
- 12 April 2024
- journal article
- research article
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 659, 124117
Abstract
No abstract availableKeywords
Funding Information
- Chinese Academy of Medical Sciences (2019-I2M-5-013)
- National Natural Science Foundation of China (32030065)
- National Natural Science Foundation of China (92049304)
- National Natural Science Foundation of China (31722033)
- East China University of Science and Technology
- Shanghai Municipal Education Commission (Tech 03-28)
- Science and Technology Commission of Shanghai Municipality (11DZ2260600)
- Science and Technology Commission of Shanghai Municipality (10DZ2220500)
- State Key Laboratory of Bioreactor Engineering
- Fundamental Research Funds for the Central Universities
This publication has 49 references indexed in Scilit:
- Hydrogen sulfide responsive nanoplatforms: Novel gas responsive drug delivery carriers for biomedical applicationsAsian Journal of Pharmaceutical Sciences, 2023
- Nanomedicine for the treatment of diabetes-associated cardiovascular diseases and fibrosisAdvanced Drug Delivery Reviews, 2021
- Therapeutic Opportunities in Inflammatory Bowel Disease: Mechanistic Dissection of Host-Microbiome RelationshipsCell, 2019
- A superoxide dismutase/catalase mimetic nanomedicine for targeted therapy of inflammatory bowel diseaseBiomaterials, 2016
- The use of sirolimus (rapamycin) in the management of refractory inflammatory bowel disease in childrenJournal of Crohn's and Colitis, 2014
- Defining the Role of Sirolimus in the Management of Graft-versus-Host Disease: From Prophylaxis to TreatmentTransplantation and Cellular Therapy, 2013
- Proinflammatory cytokines and IL-10 in inflammatory bowel disease and colorectal cancer patientsArchivum Immunologiae et Therapiae Experimentalis, 2009
- LC3 conjugation system in mammalian autophagyThe International Journal of Biochemistry & Cell Biology, 2004
- Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF‐kappa B transcription factor and HIV‐1.The EMBO Journal, 1991
- Cytoskeleton as a target in menadione‐induced oxidative stress in cultured mammalian cells. I. Biochemical and immunocytochemical featuresJournal of Cellular Physiology, 1990